About Medley Pharmaceuticals
Medley Pharmaceuticals is a company based in Mumbai (India) founded in 1969 by Sahir Khatib, Sarosh Sami Khatib, and Suhel Sami Khatib. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. Medley Pharmaceuticals has raised $39.46 thousand across 1 funding round from investors including K A Syed, Supriyo Lahiry and Syed Quazi. The company has 2,852 employees as of February 27, 2025. Medley Pharmaceuticals offers products and services including Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare.
- Headquarter Mumbai, India
- Employees 2852 as on 27 Feb, 2025
- Founders Sahir Khatib, Sarosh Sami Khatib, Suhel Sami Khatib
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medley Pharmaceuticals Ltd.
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$120.95 M (USD)12.39as on Mar 31, 2024
-
Net Profit
$20.51 M (USD)23.89as on Mar 31, 2024
-
EBITDA
$26.01 M (USD)16.25as on Mar 31, 2024
-
Total Equity Funding
$39.46 K (USD)
in 1 rounds
-
Latest Funding Round
$39.46 K (USD), Angel Round
Mar 19, 2012
-
Investors
& 13 more
-
Employee Count
2852
as on Feb 27, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medley Pharmaceuticals
Medley Pharmaceuticals offers a comprehensive portfolio of products and services, including Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare.
Products for analgesic and anti-inflammatory treatments are offered.
Haematinic and anti-infertility solutions are provided by Nutrakare.
Anti-hypertensive and anti-diabetic drugs are included in Vazokare.
Anti-diabetic and lipid-lowering agents are offered by Glycekare.
Anti-osteoporotic and muscle relaxant products are provided here.
People of Medley Pharmaceuticals
Unlock access to complete
Funding Insights of Medley Pharmaceuticals
Medley Pharmaceuticals has successfully raised a total of $39.46K through 1 strategic funding round. The most recent funding activity was a Angel Round of $39.46 thousand completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medley Pharmaceuticals
Medley Pharmaceuticals has secured backing from 14 investors, including angel investors. Prominent investors backing the company include K A Syed, Supriyo Lahiry and Syed Quazi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
KA
K A Syed |
-
|
Locked | Locked | Locked |
|
SL
Supriyo Lahiry |
-
|
Locked | Locked | Locked |
|
SQ
Syed Quazi |
-
|
Locked | Locked | Locked |
Investor details for Medley Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medley Pharmaceuticals
Investment portfolio details for Medley Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medley Pharmaceuticals
Detailed financials for Medley Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medley Pharmaceuticals Comparisons
Peer comparison for Medley Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medley Pharmaceuticals
Detailed competitors of Medley Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medley Pharmaceuticals
Complete news archive for Medley Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medley Pharmaceuticals
Medley Pharmaceuticals was founded in 1969 and raised its 1st funding round 43 years after it was founded.
Medley Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Medley Pharmaceuticals is a funded company, having raised a total of $39.46K across 1 funding round to date.
As of Feb 27, 2025, the latest employee count at Medley Pharmaceuticals is 2,852.
Annual revenue of Medley Pharmaceuticals is $120.95M as on Mar 31, 2024.
Medley Pharmaceuticals is involved in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates across various therapeutic segments including analgesics, anti-inflammatory drugs, antibiotics, anti-diabetics, and anti-hypertensive medications. Facilities are maintained with high-quality standards adhering to Good Manufacturing Practices (GMP). Operations are supported by state-of-the-art infrastructure in multiple locations across India and international collaborations in regions like South East Asia, Middle East, Africa, CIS, and Europe. Solutions are provided through divisions such as Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare, addressing diverse healthcare needs.
Medley Pharmaceuticals offers Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare.
Medley Pharmaceuticals has 14 investors. Key investors include K A Syed, Supriyo Lahiry, Syed Quazi, Raju Deshmukh, and Vikash Anand.
The valuation of Medley Pharmaceuticals is $76.23M as of Mar 2012.